Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet

v2.4.0.8
Balance Sheet (USD $)
Mar. 31, 2014
Dec. 31, 2013
Current Assets:    
Cash and cash equivalents $ 40,073,018 $ 18,688,031
Marketable securities (note 2) 100,000 100,000
Prepaid expenses and other current assets (note 3) 725,469 507,165
Total Current Assets 40,898,487 19,295,196
Restricted Cash Equivalents (note 13) 163,530 196,130
Equipment, Net (note 4) 59,899 65,172
Total Assets 41,121,916 19,556,498
Current Liabilities:    
Accounts payable and accrued expenses (note 5) 878,500 933,758
Deferred Research and Development Arrangements (note 6) 782,280 833,630
Other Liabilities (note 7) 138,278 129,564
Warrant Liabilities (note 11) 11,290,566 5,034,058
Total Liabilities 13,089,624 6,931,010
Commitments and Contingencies (note 13)      
Stockholders' Equity (note 9):    
Preferred stock, par value $0.0001, 100,000,000 authorized shares, none issued and outstanding 0 0
Common stock, par value $0.0001, 500,000,000 authorized shares, 176,655,340 and 146,732,000 issued and 176,641,135 and 146,717,795 oustanding 17,665 14,673
Additional paid-in capital 115,454,243 85,449,932
Accumulated deficit during the development stage (87,411,206) (72,810,707)
Treasury stock, 14,205 shares, at cost (28,410) (28,410)
Total Stockholders' Equity 28,032,292 12,625,488
Total Liabilities and Stockholders' Equity $ 41,121,916 $ 19,556,498